@peoplevb6
Research from Washington University in 2025 highlighted that injectable weight-loss drugs like Ozempic and Wegovy doubled pancreatitis risk and increased arthritis risk by 11%, alongside heightened chances of low blood pressure and kidney disease in 215,000 patients.